New York, NY -- (SBWIRE) -- 09/21/2013 -- StockMarketIntel.com issues a special report on the following stocks: The First Marblehead Corporation (NYSE:FMD), Harmony Gold Mining Co. (ADR) (NYSE:HMY), Hecla Mining Company (NYSE:HL), Inovio Pharmaceuticals Inc (NYSEMKT:INO)
The First Marblehead Corporation (NYSE:FMD) traded with volume of 1.75 million shares in the most recent session, as compared to average volume of 1.16 million shares. During the preceding trading session, the stock showed a bearish movement of -5.79%, to the closing price of $0.726. The one month performance graph illustrated it as a percentage loser of -22.72%. The First Marblehead Corporation, a specialty finance company, together with its subsidiaries, provides loan programs on behalf of its lender clients for K-12, undergraduate, and graduate students.
Is FMD a Solid Investment at These Levels? Read This Report For Details
Harmony Gold Mining Co. (ADR) (NYSE:HMY) in prior session, moved down -5.80% and, at the end of the day, closed the session at $3.57.The stock traded with volume of 22.48 million shares in the last session, as compared to average volume of 4.42 million shares. The market capitalization of the company was of 1.55 billion. Harmony Gold Mining Company Limited engages in the exploration, extraction, processing, and smelting of gold in South Africa and Papua New Guinea.
How Should Investors Trade HMY Now? Don’t Miss out a Special Trend Analysis
The stock which exchanged over 01 million shares in the preceding session was Hecla Mining Company (NYSE:HL), as it traded with volume of 16 million shares and its average volume remained 7.40 million shares. The market capitalization of the stock remained $1.13 billion. Yesterday, the stock dropped -6.00% and closed the session at $3.29. Hecla Mining Company, together with its subsidiaries, discovers, acquires, develops, produces, and markets precious and base metals worldwide.
What HL’s Charts Are Signaling for Traders? Find Out Here
Inovio Pharmaceuticals Inc (NYSEMKT:INO) remained with negative change of -6.44% and closed prior trading session at the price of $2.18. The stock changed hands vigorously in most recent session, as it traded 7.72 million shares, which was lower than average volume of 10.82 million shares. Inovio Pharmaceuticals, Inc., together with its subsidiaries, engages in the discovery and development of synthetic vaccines and immune therapies focusing on cancers and infectious diseases.
Should INO a Buy or Sell Now? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)